PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models ; volume:14 ; number:1 ; day:18 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.7.2024), 1-14, 12.2024
- Urheber
-
Gamba, Dávid
Eijk, Nicholas van
Lányi, Katalin
Monostory, Katalin
Steinmetzer, Torsten
Marosi, András
Rácz, Anita
Bajusz, Dávid
Kruhl, Diana
Böttcher-Friebertshäuser, Eva
Pászti-Gere, Erzsébet
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-67633-2
- URN
-
urn:nbn:de:101:1-2410080805041.867508377268
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gamba, Dávid
- Eijk, Nicholas van
- Lányi, Katalin
- Monostory, Katalin
- Steinmetzer, Torsten
- Marosi, András
- Rácz, Anita
- Bajusz, Dávid
- Kruhl, Diana
- Böttcher-Friebertshäuser, Eva
- Pászti-Gere, Erzsébet
- SpringerLink (Online service)
Ähnliche Objekte (12)
In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
TMPRSS2, a novel host-directed drug target against SARS-CoV-2
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity
Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health
Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats
PK/PD modeling supports the dose-escalation decision in VIKING
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry
In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
TMPRSS2, a novel host-directed drug target against SARS-CoV-2
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity
Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health
Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats
PK/PD modeling supports the dose-escalation decision in VIKING
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry
In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
TMPRSS2, a novel host-directed drug target against SARS-CoV-2
DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity
Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health
Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats
PK/PD modeling supports the dose-escalation decision in VIKING
TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
Bereich Produktion Arbeitspläne, Kader, Kollekt. Ausarbeitungen von PP PV PD PK
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry